CERA

Science and Research

PORTAL: A Multicenter, Open-Label Extension Study to Evaluate the Long-term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-related Macular Degeneration

Overview

  • Principal Investigator
Associate Professor Sanj Wickremasinghe